跳至主要内容
临床试验/KCT0002845
KCT0002845已完成未知

Efficacy of epidural steroid injection with hypertonic solution for post-herpetic neuralgia

Asan Medical Center0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
36

研究概览

简要总结

Final thirty-six patients (NS: 17, HS: 19) were included in the intention-to-treat analysis. The estimated pain intensity decreased in both groups at one and three months after the procedure (P < 0.001), without a significant group difference. The estimated ISI and MQS were not significantly different at 1 month compared with baseline but significantly decreased at 3 months in each group (P < 0.001 and P < 0.001, respectively), without group differences. In addition, there was no difference between the groups on the GPES scale at one and three months after the procedure.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 0No Limit(—)
性别
All

入选标准

  • 1) Age > 18yrs
  • 2) Patients complaining of neuralgia even after 4 months of onset of herpes zoster
  • 3) Postherpetic neuralgia involving cervical, thoracic and lumbar spinal nerve.
  • 4) Numerical rating scale (NRS) > 6
  • 5) Patients with postherpetic neuralgia who are not responsive to oral or intravenous form of analgesics
  • 6) Patients who spontaneously agreed to join the study by themselves.

排除标准

  • 1) Patients who do not agreed to join the study.
  • 2) Postherpetic neuralgia involving cranial and facial nerves.
  • 3) Patients who had epidural steroid injection within 3 months prior to screening.
  • 4) Pregnant or breast feeding patients.
  • 5) Patients who are allergic to local anesthetics, contrast dye, steroid and hypertonic solution.
  • 6) Patients with red flag signs (infection, cancer, coagulopathy, severe neurologic deficit, cauda equina syndrome)
  • 7) Patients with uncontrolled medical or psychological diseases.

研究者

相似试验